retatrutide clinical trial dose retatrutide Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Helped Adults With Diabetes

Retatrutide, an experimental weight-loss drug, has not been approved by the FDA

In clinical trials, retatrutide resulted in an average weight loss of approximately 5% of body weight in the first month, with many experiencing an appetite reduction within a few weeks

doi: 10.1016/S2213-8587(21)00246-1 21 EdqvistJRawshaniAAdielsMBjorckLLindMSvenssonAMet al

If you change your behavior as well, you might have better luck at avoiding regain

Beyond weight loss alone, Ozempic offers additional health benefits, including improved glycemic control, reduced cardiovascular risks, and positive impacts on metabolic health

Semaglutide in particular was linked with significantly lower risks of worsening depression, anxiety, or substance use disorder